The Solventum spin-off will help 3M prepare for legal settlements related to defective earplugs and water supply damages. 3M is risky due to potential future additional legal battles. 3M is a slow ...
Morgan Stanley raised the firm’s price target on Solventum (SOLV) to $73 from $60 and keeps an Equal Weight rating on the shares. Solventum, which “had a clean 3Q print,” seems to be navigating a ...
It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal to ...
Hosted on MSN
Solventum’s (NYSE:SOLV) Q3: Beats On Revenue
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 CY2025 results , but sales were flat year on year at $2.10 billion. Its non-GAAP profit of $1.50 per share was 4.7% above analysts’ ...
7 analysts have shared their evaluations of Solventum (NYSE:SOLV) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...
Solventum SOLV is scheduled to release third-quarter 2025 results on Nov. 6, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 16.55%. SOLV ...
Analysts are changing their tune on Solventum as 2025 comes to a close, as analysts at BTIG upgrade the company to “buy” in the final month of the year. Solventum has spent the last year routinely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback